The role of OPN in the progression of cardiovascular diseases and heart failure is undeniable, and it was demonstrated in studies utilizing OPN-null mice and experiments with its depletion by neutralizing antibodies or via targeted mutagenesis (reviewed in [163,164]). The gene discussed is SPP1; the disease is heart failure.